Cover Image
市場調查報告書

產前·新生兒遺傳基因檢查市場:全球產業分析·規模·市場佔有率·成長與趨勢與預測

Prenatal and New-born Genetic Testing Market (PCR, FISH, aCGH, NIPT and MSS): Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2013 - 2019

出版商 Transparency Market Research 商品編碼 297659
出版日期 內容資訊 英文 87 pages
商品交期: 最快1-2個工作天內
價格
Back to Top
產前·新生兒遺傳基因檢查市場:全球產業分析·規模·市場佔有率·成長與趨勢與預測 Prenatal and New-born Genetic Testing Market (PCR, FISH, aCGH, NIPT and MSS): Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2013 - 2019
出版日期: 2014年03月21日 內容資訊: 英文 87 pages
簡介

本報告提供全球產前·新生兒遺傳基因檢查市場 (PCR, FISH, aCGH, NIPT 及 MSS)的現況與預測調查分析,提供市場促進成長要素,阻礙成長要素,及機會分析,彙整各地區的市場魅力分析與波特的五力分析,及主要企業簡介等,為您概述為以下內容。

第1章 簡介

第2章 摘要整理

第3章 產前·新生兒遺傳基因檢查市場概要

  • 簡介·市場定義
  • 未來市場展望
  • 產前·新生兒篩檢的法規·醫療費給付情形
  • 市場動態
  • 波特的五力分析
  • 市場魅力分析

第4章 產前·新生兒遺傳基因檢查市場:各技術

  • 概要
    • 市場收益:各技術
  • 診斷技術
    • 市場收益:各類型
    • 聚合酵素鏈鎖反應(PCR)
    • 螢光原位雜交分析(FISH)
    • 微陣列比較基因組雜合(aCGH)
  • 篩檢手法
    • 全球篩檢手法市場收益:各類型
    • 非侵襲性產前診斷(MaterniT21 PLUS, Verifi, Harmony, Panorama, NIFTY, PrenaTest and Bambni Test)
    • 母體血清篩檢(MSS)

第5章 產前·新生兒遺傳基因檢查市場:各地區

  • 概要
  • 北美
  • 歐洲
  • 亞太地區
  • 其他地區

第6章 競爭情形

  • 市場佔有率分析:各主要企業

第7章 建議

  • 成功的市場策略
  • 障礙·未來的前提

第8章 企業簡介

  • Agilent Technologies, Inc.
    • 企業概要
    • 財務概要
    • 產品系列
    • 商務策略
    • 近幾年的發展
  • Ariosa Diagnostics, Inc.
  • Bio-Rad Laboratories, Inc.
  • Illumina, Inc.
  • Laboratory Corporation of America Holdings (LabCorp)
  • Natera, Inc.
  • PerkinElmer, Inc.
  • Sequenom, Inc.

圖表清單

目錄

Prenatal testing and diagnosis have enabled the detection of certain genetic abnormalities in as early as 8 to 10 weeks of gestation and also helps to determine the sex of the fetus. Prenatal and newborn genetic testing is referred to as the utilization of screening/diagnostic procedures for a fetus or a new born baby to detect chromosomal abnormalities such as Down syndrome, Patau syndrome and Edward syndrome. This report studies the global prenatal and newborn genetic testing market from two perspectives namely, types of technologies and the major geographic markets. The global prenatal and newborn genetic testing market by technology has been segmented as diagnostic technique and screening methods. Diagnostic technique is further classified as polymerase chain reaction (PCR), fluorescence in situ hybridization (FISH) and array-comparative genomic hybridization (aCGH). Similarly, screening methods are further categorized as non-invasive prenatal tests and maternal serum screening.

Geographically, the report segments the global prenatal and newborn genetic testing market into four main regions namely, North America, Europe, Asia-Pacific and Rest of the World (RoW). The market sizes and forecasts for the period 2011 to 2019 in terms of revenue (USD million), considering 2012 as the base year, have been provided for each technology type and geographic region, along with their sub-segments (if any). The prenatal and newborn genetic testing market report also provides compounded annual growth rate (CAGR %) during the forecast period 2013 to 2019 for all the aforementioned segments.

The market overview section of the prenatal and newborn genetic testing market report discusses the market dynamics with respect to market drivers, restraints and opportunities. This section also covers market attractiveness analysis (by geography) and Porter's five forces analysis for the global prenatal and newborn genetic testing market. Market share (%) for the major players operating in prenatal and newborn genetic testing market has also been provided for the year 2012, followed by a list of recommendations for the existing and new players to enter and enhance their market shares. The report concludes with the company profiles of key players operating in various segments of prenatal and newborn genetic testing market. Each company profile includes the business overview, financial overview, product portfolio, business strategies and recent developments of the respective company. Some of the prominent players in the prenatal and newborn genetic testing market that have been profiled in this report include Agilent Technologies, Inc., Bio-Rad Laboratories, Inc., Natera, Inc. and Illumina, Inc.

Table of Contents

Chapter 1 Introduction

  • 1.1 Report Description
  • 1.2 Market Segmentation
  • 1.3 Research Methodology
    • 1.3.1 Sources
  • 1.4 List of Abbreviations

Chapter 2 Executive Summary

  • 2.1 Market Snapshot: Global Prenatal and Newborn Genetic Testing Market (2012 & 2019)
  • 2.2 Global Prenatal and Newborn Genetic Testing Market, by Segments, 2012 (USD Million)

Chapter 3 Prenatal and Newborn Genetic Testing Market Overview

  • 3.1 Introduction and Market Definition
  • 3.2 Future Market Outlook
  • 3.3 Regulatory and Reimbursement Scenario for Prenatal and Newborn Screening
  • 3.4 Market Dynamics
    • 3.4.1 Drivers
    • 3.4.2 Restraints
    • 3.4.3 Market Opportunities
  • 3.5 Porter's Five Forces Analysis: Global Prenatal and Newborn Genetic Testing Market
    • 3.5.1 Bargaining Power of Suppliers
    • 3.5.2 Bargaining Power of Buyers
    • 3.5.3 Threat of Substitutes
    • 3.5.4 Threat of New Entrants
    • 3.5.5 Competitive Rivalry
  • 3.6 Market Attractiveness Analysis

Chapter 4 Prenatal and Newborn Genetic Testing Market, by Technology

  • 4.1 Overview
    • 4.1.1 Global Prenatal and Newborn Genetic Testing Market Revenue, by Technology, 2012 - 2019 (USD Million)
  • 4.2 Diagnostic Techniques
    • 4.2.1 Global Diagnostic Techniques Market Revenue, by Types, 2012 - 2019 (USD Million)
    • 4.2.2 Polymerase Chain Reaction (PCR)
    • 4.2.3 Fluorescence In-Situ Hybridization (FISH)
    • 4.2.4 Array-Comparative Genomic Hybridization (aCGH)
  • 4.3 Screening Methods
    • 4.3.1 Global Screening Methods Market Revenue, by Types, 2012 - 2019 (USD Million)
    • 4.3.2 Non-invasive Prenatal Tests (MaterniT21 PLUS, Verifi, Harmony, Panorama, NIFTY, PrenaTest and Bambni Test)
    • 4.3.3 Maternal Serum Screening (MSS)

Chapter 5 Prenatal and Newborn Genetic Testing Market, by Geography

  • 5.1 Overview
    • 5.1.1 Global Prenatal and Newborn Genetic Testing Market Revenue, by Geography2012 - 2019 (USD Million)
  • 5.2 North America
    • 5.2.1 North America Prenatal and Newborn Genetic Testing Market Revenue, by Technology, 2012 - 2019 (USD Million)
    • 5.2.2 North America Diagnostic Techniques Market Revenue, by Types, 2012 - 2019 (USD Million)
    • 5.2.3 North America Screening Methods Market Revenue, by Types, 2012 - 2019 (USD Million)
  • 5.3 Europe
    • 5.3.1 Europe Prenatal and Newborn Genetic Testing Market Revenue, by Technology, 2012 - 2019 (USD Million)
    • 5.3.2 Europe Diagnostic Techniques Market Revenue, by Types, 2012 - 2019 (USD Million)
    • 5.3.3 Europe Screening Methods Market Revenue, by Types, 2012 - 2019 (USD Million)
  • 5.4 Asia - Pacific
    • 5.4.1 Asia-Pacific Prenatal and Newborn Genetic Testing Market Revenue, by Technology, 2012 - 2019 (USD Million)
    • 5.4.2 Asia-Pacific Diagnostic Techniques Market Revenue, by Types, 2012 - 2019 (USD Million)
    • 5.4.3 Asia-Pacific Screening Methods Market Revenue, by Types, 2012 - 2019 (USD Million)
  • 5.5 Rest of the World (RoW)
    • 5.5.1 RoW Prenatal and Newborn Genetic Testing Market Revenue, by Technology, 2012 - 2019 (USD Million)
    • 5.5.2 RoW Diagnostic Techniques Market Revenue, by Types, 2012 - 2019 (USD Million)
    • 5.5.3 RoW Screening Methods Market Revenue, by Types, 2012 - 2019 (USD Million)

Chapter 6 Competitive Landscape

  • 6.1 Market Share Analysis, by Key Players, 2012 (%)

Chapter 7 Recommendations

  • 7.1 Market Strategy for Success
    • 7.1.1 Focus on forming alliances with diagnostic service providers in Asia-Pacific countries
    • 7.1.2 Emphasis on improving technology in order to increase accuracy, reduce the duration of result generation and price
  • 7.2 Barriers and Future Assumptions
    • 7.2.1 Lack of awareness about prenatal and newborn genetic testing in some Asian countries
    • 7.2.2 Regulatory compliance and ethical issues

Chapter 8 Company Profiles

  • 8.1 Agilent Technologies, Inc.
    • 8.1.1 Company Overview
    • 8.1.2 Financial Overview
    • 8.1.3 Product Portfolio
    • 8.1.4 Business Strategies
    • 8.1.5 Recent Developments
  • 8.2 Ariosa Diagnostics, Inc.
    • 8.2.1 Company Overview
    • 8.2.2 Financial Overview
    • 8.2.3 Product Portfolio
    • 8.2.4 Business Strategies
    • 8.2.5 Recent Developments
  • 8.3 Bio-Rad Laboratories, Inc.
    • 8.3.1 Company Overview
    • 8.3.2 Financial Overview
    • 8.3.3 Product Portfolio
    • 8.3.4 Business Strategies
    • 8.3.5 Recent Developments
  • 8.4 Illumina, Inc.
    • 8.4.1 Company Overview
    • 8.4.2 Financial Performance
    • 8.4.3 Product Portfolio
    • 8.4.4 Business Strategies
    • 8.4.5 Recent Developments
  • 8.5 Laboratory Corporation of America Holdings (LabCorp)
    • 8.5.1 Company Overview
    • 8.5.2 Financial Overview
    • 8.5.3 Product Portfolio
    • 8.5.4 Business Strategies
    • 8.5.5 Recent Developments
  • 8.6 Natera, Inc.
    • 8.6.1 Company Overview
    • 8.6.2 Financial Overview
    • 8.6.3 Product Portfolio
    • 8.6.4 Business Strategies
    • 8.6.5 Recent Developments
  • 8.7 PerkinElmer, Inc.
    • 8.7.1 Company Overview
    • 8.7.2 Financial Overview
    • 8.7.3 Product Portfolio
    • 8.7.4 Business Strategies
    • 8.7.5 Recent Developments
  • 8.8 Sequenom, Inc.
    • 8.8.1 Company Overview
    • 8.8.2 Financial Overview
    • 8.8.3 Product Portfolio
    • 8.8.4 Business Strategies
    • 8.8.5 Recent Developments

List of Figures

  • FIG. 1 Prenatal and Newborn Genetic Testing: Market Segmentation
  • FIG. 2 Global Prenatal and Newborn Genetic Testing Market, by Segments, 2012 (USD Million)
  • FIG. 3 Adoption Curve Analysis for Genetic Testing Market
  • FIG. 4 Porter's Five Forces Analysis: Global Prenatal and Newborn Genetic Testing Market
  • FIG. 5 Market Attractiveness Analysis: Global Prenatal and Newborn Genetic Testing Market, 2012
  • FIG. 6 Global PCR Market Revenue, 2012 - 2019 (USD Million)
  • FIG. 7 FISH Procedural Steps
  • FIG. 8 Global FISH Market Revenue, 2012 - 2019 (USD Million)
  • FIG. 9 Global aCGH Market Revenue, 2012 - 2019 (USD Million)
  • FIG. 10 Global NIPT Market Revenue, 2012 - 2019 (USD Million)
  • FIG. 11 Global MSS Market Revenue, 2012 - 2019 (USD Million)
  • FIG. 12 Global Prenatal and Newborn Genetic Testing: Market Share, by Key Players, 2012 (%)
  • FIG. 13 Annual Sales: Agilent Technologies, Inc., 2010 - 2012 (USD Million)
  • FIG. 14 Annual Sales: Bio-Rad Laboratories, Inc., Clinical Diagnostics Segment, 2010 - 2012 (USD Million)
  • FIG. 15 Annual Sales: Illumina, Inc., 2010 - 2012 (USD million)
  • FIG. 16 Annual Sales: LabCorp, 2010- 2012 (USD Million)
  • FIG. 17 Annual Sales: PerkinElmer, Inc. (Human Health Segment), 2010 - 2012 (USD Million)
  • FIG. 18 Annual Sales: Sequenom Inc., 2010-2012 (USD Million)

List of Tables

  • TABLE 1 Market Snapshot: Global Prenatal and Newborn Genetic Testing Market (2012 & 2019)
  • TABLE 2 Technological Approach for Non-Invasive Prenatal Screening Tests
  • TABLE 3 Global Prenatal and Newborn Genetic Testing Market Revenue, by Technology, 2012 - 2019 (USD Million)
  • TABLE 4 Global Diagnostic Techniques Market Revenue, by Types, 2012 - 2019 (USD Million)
  • TABLE 5 Global Screening Methods Market Revenue, by Types, 2012 - 2019 (USD Million)
  • TABLE 6 Global Prenatal and Newborn Genetic Testing Market Revenue, by Geography, 2012 - 2019 (USD Million)
  • TABLE 7 North America Prenatal and Newborn Genetic Testing Market Revenue, by Technology, 2012 - 2019 (USD Million)
  • TABLE 8 North America Diagnostic Techniques Market Revenue, by Types, 2012 - 2019 (USD Million)
  • TABLE 9 North America Screening Methods Market Revenue, by Types, 2012 - 2019 (USD Million)
  • TABLE 10 Europe Prenatal and Newborn Genetic Testing Market Revenue, by Technology, 2012 - 2019 (USD Million)
  • TABLE 11 Europe Diagnostic Techniques Market Revenue, by Types, 2012 - 2019 (USD Million)
  • TABLE 12 Europe Screening Methods Market Revenue, by Types, 2012 - 2019 (USD Million)
  • TABLE 13 Asia-Pacific Prenatal and Newborn Genetic Testing Market Revenue, by Technology, 2012 - 2019 (USD Million)
  • TABLE 14 Asia-Pacific Diagnostic Techniques Market Revenue, by Types, 2012 - 2019 (USD Million)
  • TABLE 15 Asia-Pacific Screening Methods Market Revenue, by Types, 2012 - 2019 (USD Million)
  • TABLE 16 RoW Prenatal and Newborn Genetic Testing Market Revenue, by Technology, 2012 - 2019 (USD Million)
  • TABLE 17 RoW Diagnostic Techniques Market Revenue, by Types, 2012 - 2019 (USD Million)
  • TABLE 18 RoW Screening Methods Market Revenue, by Types, 2012 - 2019 (USD Million)
Back to Top